Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع ادوية الصباغ - sabbagh drug store - mupirocin 2 % - 2%

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

middle east pharmaceutical industries co ltd avalon pharma, saudi arabia - mupirocin calcium - nasal ointment - 2 %

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer limited - thiothixene - tablets - 10 milligram

Kenya - English - Pharmacy and Poisons Board

navana pharmaceuticals ltd. house 99, road 4, block #b, banani dhaka -1213 - ambroxo hcl bp - syrup - ambroxo hcl bp 15mg - cough suppressants and mucolytics

Kenya - English - Pharmacy and Poisons Board

navana pharmaceuticals ltd. house 99, road 4, block #b, banani dhaka -1213 - diclofenac sodium bp - capsule - diclofenac sodium bp 100mg - diclofenac

Singapore - English - HSA (Health Sciences Authority)

spd scientific pte ltd - microbiology - the cepheid xpert vana/vanb assay, performed on genexpert instrument systems, is a qualitative in vitro diagnostic test designed for rapid detection of vancomycin-resistance (vana/vanb) genes from rectal and perianal swab specimens in patients at risk for intestinal colonization of vancomycin-resistant bacteria. the test utilizes automated real-time polymerase chain reaction (pcr) to detect the vana and vanb genes that can be associated with vancomycin-resistant enterococci (vre). the xpert vana/vanb assay is intended to aid in the recognition, prevention and control of vancomycin-resistant organism colonization in healthcare settings. the xpert vana/vanb assay is not intended to diagnose vre nor to guide or monitor treatment for vre infections. concomitant cultures are necessary only to recover organisms for epidemiological typing, susceptibility testing and for further confirmatory identification of vre.

Singapore - English - HSA (Health Sciences Authority)

vela operations singapore pte. ltd. - microbiology - the sentosa™ sa vana/vanb pcr test is a real-time polymerase chain reaction (pcr) based in vitro diagnostic test, for the qualitative detection and differentiation of vancomycin resistance (vana and vanb) genes that can be associated with vancomycin-resistant enterococcus (vre). it detects vana and vanb genotypes in rectal and / or perianal swab samples from patients at risk for nosocomial drug resistance infections, together with clinical and epidemiological risk factors. this in vitro diagnostic test is validated for use on the sentosa™ sx101 instrument, with the sentosa™ sx bacteria gdna kit v2.0, in conjunction with the rotor-gene® q mdx 5plex hrm instrument. the test results can be used as supplementary data for diagnosis, or large scale screening of vancomycin resistant colonization in healthcare settings. negative results do not preclude vre infection and should not be used as a sole basis for treatment and other patient management decisions.

Bangladesh - English - DGDA (Directorate General of Drug Administration)

navana health care limited - butaphosphan + cyanocobalamin - injection - 10 gm + 5 mg/100 ml

Bangladesh - English - DGDA (Directorate General of Drug Administration)

navana health care limited - ceftriaxone - injection - 1 gm/vial

Bangladesh - English - DGDA (Directorate General of Drug Administration)

navana health care limited - ceftriaxone - injection - 2 gm/vial